Registration number:
A & E Healthcare Limited
for the Year Ended 30 November 2017
18 Tamar Close
Bere Alston
Yelverton
Devon
PL20 7HF
A & E Healthcare Limited
Contents
|
Company Information |
|
|
Director's Report |
|
|
Accountants' Report |
|
|
Profit and Loss Account |
|
|
Statement of Comprehensive Income |
|
|
Balance Sheet |
|
|
Statement of Changes in Equity |
|
|
Notes to the Financial Statements |
A & E Healthcare Limited
Company Information
|
Director |
Ashley Hunter |
|
Registered office |
|
|
Accountants |
|
|
Page 1 |
A & E Healthcare Limited
Director's Report for the Year Ended 30 November 2017
The director presents his report and the financial statements for the year ended 30 November 2017.
Director of the company
The director who held office during the year was as follows:
Principal activity
The principal activity of the company is sale and distribution of pharmaceutical supplies
Small companies provision statement
This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
Approved by the
.........................................
Ashley Hunter
Highest paid director
|
Page 2 |
Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
A & E Healthcare Limited
for the Year Ended 30 November 2017
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of A & E Healthcare Limited for the year ended 30 November 2017 as set out on pages 4 to 12 from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/en/members/regulations-standards-and-guidance/.
This report is made solely to the Board of Directors of A & E Healthcare Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of A & E Healthcare Limited and state those matters that we have agreed to state to the Board of Directors of A & E Healthcare Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than A & E Healthcare Limited and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that A & E Healthcare Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of A & E Healthcare Limited. You consider that A & E Healthcare Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of A & E Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
......................................
Bere Alston
Yelverton
Devon
PL20 7HF
|
Page 3 |
A & E Healthcare Limited
Profit and Loss Account for the Year Ended 30 November 2017
|
Note |
2017 |
2016 |
|
|
Turnover |
|
|
|
|
Cost of sales |
( |
( |
|
|
Gross profit |
|
|
|
|
Administrative expenses |
( |
( |
|
|
Operating (loss)/profit |
( |
|
|
|
(Loss)/profit before tax |
( |
|
|
|
Taxation |
|
- |
|
|
(Loss)/profit for the financial year |
( |
|
The above results were derived from continuing operations.
The company has no recognised gains or losses for the year other than the results above.
|
Page 4 |
A & E Healthcare Limited
Statement of Comprehensive Income for the Year Ended 30 November 2017
|
2017 |
2016 |
|
|
(Loss)/profit for the year |
( |
|
|
Total comprehensive income for the year |
( |
|
|
Page 5 |
A & E Healthcare Limited
(Registration number: 06739463)
Balance Sheet as at 30 November 2017
|
Note |
2017 |
2016 |
|
|
Fixed assets |
|||
|
Tangible assets |
|
|
|
|
Current assets |
|||
|
Stocks |
|
|
|
|
Debtors |
|
|
|
|
Cash at bank and in hand |
|
|
|
|
|
|
||
|
Creditors: Amounts falling due within one year |
( |
( |
|
|
Net current assets |
|
|
|
|
Total assets less current liabilities |
|
|
|
|
Provisions for liabilities |
( |
( |
|
|
Net assets |
|
|
|
|
Capital and reserves |
|||
|
Called up share capital |
|
|
|
|
Capital redemption reserve |
|
|
|
|
Profit and loss account |
|
|
|
|
Total equity |
|
|
For the financial year ending 30 November 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
|
• |
|
|
• |
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
Approved and authorised by the
.........................................
Ashley Hunter
Director
|
Page 6 |
A & E Healthcare Limited
Statement of Changes in Equity for the Year Ended 30 November 2017
|
Share capital |
Capital redemption reserve |
Profit and loss account |
Total |
|
|
At 1 December 2016 |
|
|
|
|
|
Loss for the year |
- |
- |
( |
( |
|
Total comprehensive income |
- |
- |
( |
( |
|
Dividends |
- |
- |
( |
( |
|
At 30 November 2017 |
|
|
|
|
|
Share capital |
Capital redemption reserve |
Profit and loss account |
Total |
|
|
At 1 December 2016 |
1 |
1 |
13,438 |
13,440 |
|
Profit for the year |
- |
- |
|
|
|
Total comprehensive income |
- |
- |
|
|
|
At 30 November 2016 |
|
|
|
|
|
Page 7 |
A & E Healthcare Limited
Notes to the Financial Statements for the Year Ended 30 November 2017
|
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
These financial statements were authorised for issue by the
|
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Revenue recognition
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.
Tax
The tax expense for the period comprises deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.
|
Page 8 |
A & E Healthcare Limited
Notes to the Financial Statements for the Year Ended 30 November 2017
Tangible assets
Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
|
Asset class |
Depreciation method and rate |
|
Office equipment |
25% reducing balance |
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.
Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
|
Page 9 |
A & E Healthcare Limited
Notes to the Financial Statements for the Year Ended 30 November 2017
Dividends
Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.
|
Loss/profit before tax |
Arrived at after charging/(crediting)
|
2017 |
2016 |
|
|
Depreciation expense |
|
|
|
Page 10 |
A & E Healthcare Limited
Notes to the Financial Statements for the Year Ended 30 November 2017
|
Tangible assets |
|
Furniture, fittings and equipment |
Total |
|
|
Cost or valuation |
||
|
At 1 December 2016 |
|
|
|
At 30 November 2017 |
|
|
|
Depreciation |
||
|
At 1 December 2016 |
|
|
|
Charge for the year |
|
|
|
At 30 November 2017 |
|
|
|
Carrying amount |
||
|
At 30 November 2017 |
|
|
|
At 30 November 2016 |
|
|
|
Stocks |
|
2017 |
2016 |
|
|
Other inventories |
|
|
|
Debtors |
|
2017 |
2016 |
|
|
Trade debtors |
|
|
|
Prepayments |
|
|
|
Other debtors |
|
|
|
|
|
|
Creditors |
Creditors: amounts falling due within one year
|
Note |
2017 |
2016 |
|
|
Due within one year |
|||
|
Trade creditors |
|
|
|
|
Directors current account |
|
|
|
|
Other creditors |
|
|
|
|
|
|
|
Page 11 |
A & E Healthcare Limited
Notes to the Financial Statements for the Year Ended 30 November 2017
|
Share capital |
Allotted, called up and fully paid shares
|
2017 |
2016 |
|||
|
No. |
£ |
No. |
£ |
|
|
|
|
1 |
|
1 |
|
Dividends |
|
2017 |
2016 |
|||
|
£ |
£ |
|||
|
Interim dividend of £ |
5,000 |
- |
||
|
Related party transactions |
Directors' remuneration
The director's remuneration for the year was as follows:
|
2017 |
2016 |
|
|
Remuneration |
|
|
|
Page 12 |